Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
Lenalidomide maintains posttransplant remissions in myeloma
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 24, 2017
News
Newly diagnosed mantle cell lymphoma is ‘one of the hardest consultations’
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 21, 2017
News
Thousands expected to get CAR T-cells by 2018
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 20, 2017
News
Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 18, 2017
News

Minimal residual disease eyed for myeloma management
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 14, 2017
News

Expanded drug combinations produce best myeloma induction
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 14, 2017
News

Coverage denials plague U.S. PCSK9-inhibitor prescriptions
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 12, 2017
Opinion

Death watch intensifies for HDL-based interventions
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 10, 2017
Video

VIDEO: Blinatumomab, inotuzumab reshape relapsed ALL treatment
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 9, 2017
News

Routine U.S. mitral clip use found reassuring
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 8, 2017
Video

VIDEO: Careful TKI hiatus makes CML pregnancy possible
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 8, 2017
News

Decision tool helps patients compare SAVR, TAVR
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 7, 2017
Opinion

Stroke hospitals owe all patients rapid thrombolysis
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 5, 2017
News
New-onset AF boosts bad HFrEF outcomes
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 4, 2017
News

Gliflozins’ heart failure protection in type 2 diabetes confirmed
- Author:
- Mitchel L. Zoler, PhD
Publish date: April 4, 2017